We are live on ! Find out more
SBH

Segall Bryant & Hamill Portfolio holdings

AUM $6.98B
1-Year Est. Return 34.78%
This Fund
S&P 500
This Quarter Est. Return
-14.02%
1 Year Est. Return
+34.78%
3 Year Est. Return
+85.12%
5 Year Est. Return
+106.02%
10 Year Est. Return
+446.97%
AUM
$8.88B
AUM Growth
-$1.57B
Cap. Flow
+$103M
Cap. Flow %
1.15%
Top 10 Hldgs %
15.32%
Holding
763
New
20
Increased
297
Reduced
294
Closed
39

Top Buys

Rank Stock Value
1
UL icon
Unilever
UL
+$28M
2
PRGO icon
Perrigo
PRGO
+$25.4M
3
J icon
Jacobs Solutions
J
+$23.4M
4
ICUI icon
ICU Medical
ICUI
+$21.3M
5
SSB icon
SouthState Bank Corp
SSB
+$20.1M

Sector Composition

Rank Sector Weight
1 Technology 19.41%
2 Healthcare 18.06%
3 Industrials 15.07%
4 Financials 12.92%
5 Consumer Discretionary 8.65%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BWXT icon
251
BWX Technologies
BWXT
$15.5B
$7.15M 0.08%
129,835
-9,368
-7% -$487K
CSCO icon
252
Cisco
CSCO
$457B
$7.14M 0.08%
167,427
-168,502
-50% -$8.07M
YETI icon
253
Yeti Holdings
YETI
$3.71B
$7.11M 0.08%
164,210
+45,815
+39% +$2.23M
EHC icon
254
Encompass Health
EHC
$11B
$7.04M 0.08%
157,899
+19,478
+14% +$999K
IWM icon
255
iShares Russell 2000 ETF
IWM
$79.8B
$7.03M 0.08%
41,482
-174
-0.4% -$32.1K
CCOI icon
256
Cogent Communications
CCOI
$676M
$6.98M 0.08%
114,870
+34,179
+42% +$2.1M
GSHD icon
257
Goosehead Insurance
GSHD
$2.2B
$6.97M 0.08%
152,693
+64,366
+73% +$3.51M
OLED icon
258
Universal Display
OLED
$3.68B
$6.95M 0.08%
68,720
+9,883
+17% +$1.27M
EFOR
259
Everforth Inc
EFOR
$1.17B
$6.94M 0.08%
76,946
+22,764
+42% +$2.33M
NOVT icon
260
Novanta
NOVT
$5.08B
$6.87M 0.08%
56,673
+16,728
+42% +$2.1M
RPD icon
261
Rapid7
RPD
$645M
$6.84M 0.08%
102,328
+54,620
+114% +$4.51M
FANG icon
262
Diamondback Energy
FANG
$57.1B
$6.83M 0.08%
56,406
+2,833
+5% +$388K
FOUR icon
263
Shift4
FOUR
$4.2B
$6.79M 0.08%
205,291
+61,039
+42% +$2.88M
SILK
264
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
$6.76M 0.08%
185,876
+55,291
+42% +$2.01M
AMGN icon
265
Amgen
AMGN
$208B
$6.76M 0.08%
27,818
-531
-2% -$130K
ICE icon
266
Intercontinental Exchange
ICE
$85.6B
$6.65M 0.07%
70,539
-6,979
-9% -$746K
STEP icon
267
StepStone Group
STEP
$3.61B
$6.62M 0.07%
254,319
+75,861
+43% +$2.06M
AVTR icon
268
Avantor
AVTR
$9.32B
$6.6M 0.07%
212,191
+52,641
+33% +$1.64M
KTOS icon
269
Kratos Defense & Security Solutions
KTOS
$8.74B
$6.58M 0.07%
474,391
+140,957
+42% +$2.19M
VZ icon
270
Verizon
VZ
$195B
$6.5M 0.07%
127,901
+387
+0.3% +$19.6K
EME icon
271
Emcor
EME
$35.2B
$6.48M 0.07%
62,985
+5,169
+9% +$553K
TSM icon
272
TSMC
TSM
$2.1T
$6.47M 0.07%
79,194
-5,479
-6% -$507K
AVNT icon
273
Avient
AVNT
$3.33B
$6.42M 0.07%
160,212
+47,334
+42% +$2.24M
BMY icon
274
Bristol-Myers Squibb
BMY
$133B
$6.39M 0.07%
82,902
+2,925
+4% +$223K
AMAT icon
275
Applied Materials
AMAT
$403B
$6.38M 0.07%
70,194
+576
+0.8% +$63.2K

Similar funds

Segall Bryant & Hamill's Q2 2022 Portfolio in Review

As of Q2 2022, Segall Bryant & Hamill held 763 positions worth $8.88B, down 15% from $10.5B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Segall Bryant & Hamill's Q2 2022 filing shows 20 new, 297 increased, 294 reduced and 39 closed positions. Its largest new stake was Perrigo: 684,450 shares worth $27.7M. The largest sale was Western Alliance Bancorporation, an estimated $35M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 21% a quarter earlier, followed by Healthcare and Industrials.

  • Segall Bryant & Hamill's largest Q2 2022 buy was Perrigo: 684,450 shares worth $27.7M.
  • Segall Bryant & Hamill added most to Unilever in Q2 2022, an estimated $28M increase.
  • Segall Bryant & Hamill's biggest Q2 2022 reduction was Western Alliance Bancorporation, cutting an estimated $35M.
  • Segall Bryant & Hamill fully exited Anaplan, Inc. in Q2 2022, selling an estimated $22.7M.
  • Segall Bryant & Hamill's ten largest holdings make up 15% of its $8.88B portfolio in Q2 2022.
  • Segall Bryant & Hamill opened 20 new positions and closed 39 in Q2 2022.
  • Segall Bryant & Hamill's portfolio value fell 15% quarter-over-quarter to $8.88B.

Based on Segall Bryant & Hamill's 13F filing for Q2 2022, filed 15 Aug 2022.